Can anti–PGL-1 and anti–NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?

Classification of leprosy according to immunity. A five-group system.

D.S. Ridley, W. H. Jopling · PubMed · 1966 · 2.5K citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Simple and Fast Lateral Flow Test for Classification of Leprosy Patients and Identification of Contacts with High Risk of Developing Leprosy

Samira Bührer-Sékula, H. L. Smits, George C. Gussenhoven et al. · Journal of Clinical Microbiology · 2003 · 207 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Rapid Quantitative Serological Test for Detection of Infection with Mycobacterium leprae, the Causative Agent of Leprosy

Malcolm S. Duthie, Marivic Balagon, Armi Maghanoy et al. · Journal of Clinical Microbiology · 2013 · 94 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Risk factors for type-1 reactions in borderline leprosy patients

Paul Roche, W. J. Theuvenet, Warwick J. Britton · The Lancet · 1991 · 69 citations

Life Sciences, Immunology, Infectious Diseases +8

Utility of measuring serum levels of anti‐PGL‐I antibody, neopterin and C‐reactive protein in monitoring leprosy patients during multi‐drug treatment and reactions

Eliane Aparecida Silva, Anand M. Iyer, Shogo Ura et al. · Tropical Medicine & International Health · 2007 · 55 citations

Life Sciences, Dermatology, Immunology +15